Imatinib therapy for non-infection-related type II cryoglobulinemia with membranoproliferative glomerulonephritis

American Journal of Kidney Diseases

Volumn 59, Issue 1, 2012, Pages 122-125

  Wallace, Eric ^a   Fogo, Agnes B ^a   Schulman, Gerald ^a  

^a VANDERBILT UNIVERSITY   (United States)

Author keywords

cryoglobulinemia; Gleevec; Imatinib; membranoproliferative glomerulonephritis

Indexed keywords

CREATININE; CRYOGLOBULIN; IMATINIB; LISINOPRIL; METHYLPREDNISOLONE; PREDNISONE; STEROID;

ADULT; ARTICLE; CASE REPORT; CRYOGLOBULINEMIA; DISEASE SEVERITY; DRUG DOSE INCREASE; ERYTHROCYTE SEDIMENTATION RATE; HUMAN; HUMAN TISSUE; KIDNEY BIOPSY; KIDNEY DISEASE; LABORATORY TEST; MALE; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; PHYSICAL EXAMINATION; PLASMAPHERESIS; PROTEINURIA;

CRYOGLOBULINEMIA; GLOMERULONEPHRITIS, MEMBRANOPROLIFERATIVE; HUMANS; MALE; MIDDLE AGED; PIPERAZINES; PROTEIN KINASE INHIBITORS; PYRIMIDINES;

EID: 83655191946     PISSN: 02726386     EISSN: 15236838     Source Type: Journal    
DOI: 10.1053/j.ajkd.2011.08.016     Document Type: Article

References (18)

1. V. Rieu, P. Cohen, M.H. Andre Characteristics and outcome of 49 patients with symptomatic cryoglobulinaemia Rheumatology (Oxford) 41 3 2002 290 300
2. K.R. Carson, A.M. Evens, E.A. Richey Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project Blood 113 20 2009 4834 4840
3. B.J. Druker, M. Talpaz, D.J. Resta Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia N Engl J Med 344 14 2001 1031 1037
4. M. Carroll, S. Ohno-Jones, S. Tamura CGP 57148, a tyrosine kinase inhibitor, inhibits the growth of cells expressing BCR-ABL, TEL-ABL, and TEL-PDGFR fusion proteins Blood 90 12 1997 4947 4952
5. S. Wang, M.C. Wilkes, E.B. Leof, R. Hirschberg Imatinib mesylate blocks a non-Smad TGF-beta pathway and reduces renal fibrogenesis in vivo FASEB J 19 1 2005 1 11
6. R.E. Gilbert, D.J. Kelly, T. McKay PDGF signal transduction inhibition ameliorates experimental mesangial proliferative glomerulonephritis Kidney Int 59 4 2001 1324 1332
7. M. Lassila, K. Jandeleit-Dahm, K.K. Seah Imatinib attenuates diabetic nephropathy in apolipoprotein E-knockout mice J Am Soc Nephrol 16 2 2005 363 373
8. J. Savikko, E. Taskinen, E. Von Willebrand Chronic allograft nephropathy is prevented by inhibition of platelet-derived growth factor receptor: tyrosine kinase inhibitors as a potential therapy Transplantation 75 8 2003 1147 1153
9. Savikko J, Rintala JM, Rintala SE, Koskinen PK, von Willebrand E. Early short-term imatinib treatment is sufficient to prevent the development of chronic allograft nephropathy [published online ahead of print February 1, 2011]. Nephrol Dial Transplant.
10. R.T. Paniagua, O. Sharpe, P.P. Ho Selective tyrosine kinase inhibition by imatinib mesylate for the treatment of autoimmune arthritis J Clin Invest 116 10 2006 2633 2642
11. C. Zoja, D. Corna, D. Rottoli, C. Zanchi, M. Abbate, G. Remuzzi Imatinib ameliorates renal disease and survival in murine lupus autoimmune disease Kidney Int 70 1 2006 97 103
12. V. Agosti, S. Corbacioglu, I. Ehlers Critical role for Kit-mediated Src kinase but not PI 3-kinase signaling in pro T and pro B cell development J Exp Med 199 6 2004 867 878
13. M. Iyoda, K.L. Hudkins, S. Becker-Herman Imatinib suppresses cryoglobulinemia and secondary membranoproliferative glomerulonephritis J Am Soc Nephrol 20 1 2009 68 77
14. S. Guo, J. Kowalewska, T.A. Wietecha Renin-angiotensin system blockade is renoprotective in immune complex-mediated glomerulonephritis J Am Soc Nephrol 19 6 2008 1168 1176
15. P.A. Zipfel, M. Grove, K. Blackburn, M. Fujimoto, T.F. Tedder, A.M. Pendergast The c-Abl tyrosine kinase is regulated downstream of the B cell antigen receptor and interacts with CD19 J Immunol 165 12 2000 6872 6879
16. S. Wang, M.C. Wilkes, E.B. Leof, R. Hirschberg Noncanonical TGF-beta pathways, mTORC1 and Abl, in renal interstitial fibrogenesis Am J Physiol Renal Physiol 298 1 2010 F142 F149
17. W.W. Tang, T.R. Ulich, D.L. Lacey Platelet-derived growth factor-BB induces renal tubulointerstitial myofibroblast formation and tubulointerstitial fibrosis Am J Pathol 148 4 1996 1169 1180
18. T. Ostendorf, S. Rong, P. Boor Antagonism of PDGF-D by human antibody CR002 prevents renal scarring in experimental glomerulonephritis J Am Soc Nephrol 17 4 2006 1054 1062